Cargando…

Factors that influence quality and yield of circulating-free DNA: A systematic review of the methodology literature

BACKGROUND: Circulating-free DNA (cfDNA) is under investigation as a liquid biopsy of cancer for early detection, monitoring disease progression and therapeutic response. This systematic review of the primary cfDNA literature aims to identify and evaluate factors that influence recovery of cfDNA, an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Trigg, R.M., Martinson, L.J., Parpart-Li, S., Shaw, J.A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2018
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6074610/ https://www.ncbi.nlm.nih.gov/pubmed/30094369 http://dx.doi.org/10.1016/j.heliyon.2018.e00699

Ejemplares similares

Circulating tumor DNA moves further into the spotlight
por: Sausen, Mark, et al.
Publicado: (2014)

Diagnostic accuracy of circulating-free DNA for the determination of MYCN amplification status in advanced-stage neuroblastoma: a systematic review and meta-analysis
por: Trigg, Ricky M., et al.
Publicado: (2020)

Early detection of pre-malignant lesions in a KRAS(G12D)-driven mouse lung cancer model by monitoring circulating free DNA
por: Rakhit, Callum P., et al.
Publicado: (2019)

Opportunities and challenges of circulating biomarkers in neuroblastoma
por: Trigg, Ricky M., et al.
Publicado: (2019)

Kinetics of circulating cell-free DNA for biomedical applications: critical appraisal of the literature
por: Khier, Sonia, et al.
Publicado: (2018)

Breitbandige Ferrit- Hochfrequenztransformatoren: Schaltungen und Systeme
por: Von Parpart, J
Publicado: (1997)

Circulating cell-free mitochondrial DNA levels in Parkinson’s disease are influenced by treatment
por: Lowes, Hannah, et al.
Publicado: (2020)

The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma
por: Yuwono, Nicole Laurencia, et al.
Publicado: (2021)

The Synaptic Scaling Literature: A Systematic Review of Methodologies and Quality of Reporting
por: Moulin, Thiago C., et al.
Publicado: (2020)

Detection of HER2 amplification in circulating free DNA in patients with breast cancer
por: Page, K, et al.
Publicado: (2011)

Abnormal DNA methylation as a cell-free circulating DNA biomarker for colorectal cancer detection: A review of literature
por: Galanopoulos, Michail, et al.
Publicado: (2017)

Reporting and methodological quality of meta-analyses in urological literature
por: Xia, Leilei, et al.
Publicado: (2017)

Circulating Cell Free DNA in the Diagnosis of Trophoblastic Tumors
por: Openshaw, Mark R., et al.
Publicado: (2015)

Circulating Cell-Free DNA or Circulating Tumor DNA in the Management of Ovarian and Endometrial Cancer
por: Chen, Qian, et al.
Publicado: (2019)

Application of Microfluidic Methodology for the Analysis of DNA
por: Shaw, Kirsty, et al.
Publicado: (2018)

Literature review and methodological considerations for understanding circulating risk biomarkers following trauma exposure
por: Linnstaedt, Sarah D, et al.
Publicado: (2019)

Cell-free circulating tumor DNA in cancer
por: Qin, Zhen, et al.
Publicado: (2016)

Role of circulating free DNA in colorectal cancer
por: Matikas, Alexios, et al.
Publicado: (2016)

Quantifying circulating cell-free DNA in humans
por: Meddeb, Romain, et al.
Publicado: (2019)

Life and death of circulating cell-free DNA
por: Kustanovich, Anatoli, et al.
Publicado: (2019)

Circulating Cell-Free DNA and Colorectal Cancer: A Systematic Review
por: Vymetalkova, Veronika, et al.
Publicado: (2018)

The Influence of DNA Configuration on the Direct Strand Break Yield
por: Bernal, M. A., et al.
Publicado: (2015)

Assessing the methodological quality of systematic reviews
por: Welsh, Emma J, et al.
Publicado: (2015)

Circulating Tumor Cell and Cell-free Circulating Tumor DNA in Lung Cancer
por: Nurwidya, Fariz, et al.
Publicado: (2016)

Can Circulating Cell-Free DNA or Circulating Tumor DNA Be a Promising Marker in Ovarian Cancer?
por: Yu, Ming, et al.
Publicado: (2021)

Methylation of cell-free circulating DNA in the diagnosis of cancer
por: Warton, Kristina, et al.
Publicado: (2015)

Circulating Cell-Free Tumour DNA in the Management of Cancer
por: Francis, Glenn, et al.
Publicado: (2015)

TP53 mutations on circulating cell-free DNA
por: Pantel, Klaus
Publicado: (2016)

Bioinformatics Analysis for Circulating Cell-Free DNA in Cancer
por: Huang, Chiang-Ching, et al.
Publicado: (2019)

Circulating cell-free DNA use for diagnosing cholangiocarcinoma
por: Sorscher, Steven
Publicado: (2019)

Origin of circulating free DNA in patients with lung cancer
por: Abe, Tomonori, et al.
Publicado: (2020)

Circulating Cell-Free DNA Is Associated With Cognitive Outcomes
por: Feger, Danielle, et al.
Publicado: (2020)

Circulating cell-free DNA for cancer early detection
por: Gao, Qiang, et al.
Publicado: (2022)

Circulating Microbial Cell-Free DNA in Health and Disease
por: Pietrzak, Bernadeta, et al.
Publicado: (2023)

Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges
por: García-Pardo, Miguel, et al.
Publicado: (2022)

Circulating tumor DNA in patients with colorectal adenomas: assessment of detectability and genetic heterogeneity
por: Myint, Ni Ni Moe, et al.
Publicado: (2018)

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic Cancer
por: Jaworski, Jedrzej J., et al.
Publicado: (2020)

Circulating Cell-Free DNA Methylation Profiles in the Early Detection of Ovarian Cancer: A Scoping Review of the Literature
por: Guo, Xiaoyue M., et al.
Publicado: (2021)

Tissue-specific cell-free DNA degradation quantifies circulating tumor DNA burden
por: Zhu, Guanhua, et al.
Publicado: (2021)

Editorial: Enzyme design methodologies to enhance enzymatic yield
por: Runthala, Ashish, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_tm85jl49dk74m51m1gf8vb6tcg